Connor, Clark & Lunn Investment Management (CC&L)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,800
Closed -$388K 1463
2024
Q1
$388K Buy
+2,800
New +$352K ﹤0.01% 1190
2022
Q4
Sell
-30,118
Closed -$2.43M 1272
2022
Q3
$2.43M Buy
30,118
+11,205
+59% +$949K 0.02% 456
2022
Q2
$1.41M Buy
18,913
+753
+4% +$68.7K 0.01% 543
2022
Q1
$2.32M Sell
18,160
-13,176
-42% -$1.44M 0.01% 466
2021
Q4
$4.21M Buy
31,336
+6,284
+25% +$903K 0.02% 363
2021
Q3
$3.42M Buy
25,052
+7,584
+43% +$956K 0.02% 414
2021
Q2
$1.86M Sell
17,468
-4,524
-21% -$434K 0.01% 554
2021
Q1
$1.98M Buy
21,992
+1,008
+5% +$94.6K 0.01% 563
2020
Q4
$1.94M Buy
20,984
+1,100
+6% +$98.2K 0.01% 515
2020
Q3
$2.05M Buy
19,884
+2,332
+13% +$244K 0.01% 477
2020
Q2
$1.78M Buy
+17,552
New +$1.57M 0.01% 480
2014
Q2
Sell
-70,000
Closed -$799K 555
2014
Q1
$799K Buy
70,000
+46,000
+192% +$475K 0.01% 418
2013
Q4
$226K Buy
+24,000
New +$190K ﹤0.01% 647

Other funds holding DXCM

Connor, Clark & Lunn Investment Management (CC&L)'s DXCM Position: Q2 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of DexCom (DXCM) in Q2 2024, closing a stake of 2,800 shares — an estimated $388K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in DXCM in Q4 2013 and held it in 13 quarters. The position peaked at $4.21M in Q4 2021. 1,000 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 2,800 DexCom shares in Q2 2024, an estimated $388K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in DexCom in Q4 2013 and held it in 13 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s DexCom position peaked at $4.21M in Q4 2021.
  • 1,000 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2024, filed 9 Aug 2024.